Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,674,173 papers from all fields of science
Search
Sign In
Create Free Account
Zolinza
Known as:
Merck brand of Vorinostat
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Vorinostat
Vorinostat 100 MG Oral Capsule [Zolinza]
Vorinostat Oral Capsule [Zolinza]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Trade Name: Zolinza Manufacturer/Distributor:
Merck Frosst
2015
Corpus ID: 167452367
2015
2015
4,5-Diaryl imidazoles with hydroxamic acid appendages as anti-hepatoma agents
P. Di Fazio
,
S. Lingelbach
,
R. Schobert
,
B. Biersack
Investigational new drugs
2015
Corpus ID: 26012283
SummaryIntroduction Hepatocellular carcinoma (HCC) is the most abundant tumour of the liver with rising patient numbers in the…
Expand
2015
2015
Synthesis of Histone Deacetylases Inhibitor and Activity in Vitro
Baoping Kuang
,
Hui Zhang
,
Zhi-Hang Shang
2015
Corpus ID: 59477382
Multi-drug resistance (MDR) is an important element which leads to ineffectiveness of chemotherapeutics. The discovery of histone…
Expand
2014
2014
Synthesis of Zolinza and other Novel Histone Deacetylase (HDAC).
Chee-Geng Chia
,
P. Oh
,
S. L. Lam
2014
Corpus ID: 85757348
2012
2012
Abstract 4707: Inhibition of autophagy overcomes acquired resistance to vorinostat
Daphne Dupéré-Richer
,
Mena Kinal
,
Filippa Pettersson
,
S. D. del Rincón
,
W. Miller
2012
Corpus ID: 70970934
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Histone deacetylase inhibitors (HDACi) have…
Expand
2011
2011
Abstract LB-353: Targeting pancreatic cancer stem cells by epigenetic regulation of miR-34a
S. Shankar
,
R. K Srivastava
2011
Corpus ID: 76605883
MicroRNA-34a (miR-34a) is a transcriptional target of p53 that is down-regulated in pancreatic cancer. This study aimed to…
Expand
2006
2006
Epigenetische Inaktivierung von Genexpression
M. Lübbert
,
R. Claus
Der Onkologe
2006
Corpus ID: 38068404
ZusammenfassungEpigenetische Alterationen bei Leukämien, Myelodysplasien (MDS), anderen hämatologischen Neoplasien sowie soliden…
Expand
2006
2006
FDA Approves Zolinza for Cutaneous T-cell Lymphoma
P. Peck
2006
Corpus ID: 155547320
ROCKVILLE, Md. -- The FDA has approved Zolinza (vorinostat) capsules as second-line therapy for cutaneous T-cell lymphoma that is…
Expand